Neko Health Establishes First U.S. Headquarters in Manhattan

Spotify co‑founder Daniel Ek has taken his health‑technology startup, Neko Health, across the Atlantic. The company, which combines body‑scanning technology with blood‑analysis services, will open its first U.S. office in Manhattan. The launch is slated for roughly a month from now, marking the firm’s initial physical presence on American soil.

Neko Health was created to streamline preventive health monitoring by integrating non‑invasive scanning tools with rapid blood‑work results. While the startup has operated out of Europe since its inception, the New York location will serve as a hub for U.S. operations, including regulatory liaison, partnership development, and talent recruitment. The move reflects a broader trend of health‑tech firms seeking proximity to major medical research institutions and venture capital ecosystems.

The Manhattan office will occupy space in a technology‑focused building, positioning the company near other digital health innovators. Although specific staffing numbers have not been disclosed, the launch is expected to create a range of roles from engineering and data science to clinical liaison and business development. Ek has hinted that the U.S. rollout will enable faster integration of Neko’s platform with American health‑care providers and insurers.

Industry observers note that the timing aligns with heightened interest in preventive health solutions, especially those that can deliver results without invasive procedures. Neko Health’s approach—leveraging AI‑driven imaging alongside point‑of‑care blood testing—aims to reduce the time between screening and diagnosis. By establishing a foothold in New York, the startup hopes to accelerate clinical trials, secure additional funding, and expand its service network across the United States.

The upcoming New York office underscores Ek’s ambition to translate his success in music streaming into the health‑tech arena. As the company prepares for its U.S. debut, stakeholders will watch closely to see how Neko Health’s technology is received by both consumers and the broader medical community.